ALG-2 |
apoptosis-linked gene-2 |
ALL |
acute lymphoblastic leukemia |
ALR |
autophagic lysosome reformation |
AMPK |
AMP-activated protein kinase |
BECs |
bladder epithelial cells |
BFRs |
brominated flame retardants |
CADs |
cationic amphiphilic drugs |
CaM |
calmodulin |
CaN |
calcineurin |
DCs |
dendritic cells |
ECM |
extracellular matrix |
GBM |
glioblastoma |
H. pylori |
Helicobacter pylori |
IFNs |
interferons |
ILVs |
intraluminal vesicles |
LMP |
lysosomal membrane permeabilization |
LSD |
lysosomal storage disease |
MLIV |
mucolipidosis type IV |
mTORC1 |
mechanistic target of rapamycin complex 1 |
MVBs |
multivesicular bodies |
NSCLC |
nonsmall-cell lung cancer |
PDAC |
pancreatic ductal adenocarcinoma |
PM |
plasma membrane |
ROS |
reactive oxygen species |
Syt7 |
synaptotagmin 7 |
TAMs |
tumor-associated macrophages |
TBBPA |
tetrabromobisphenol A |
TFEB |
transcription factor EB |
TGN |
trans-Golgi-network |
T-MPs |
tumor cell-derived microparticles |
TNBC |
Triple negative breast cancer |
TPCs |
two pore channels |
TRP |
transient receptor potential |
TRPA1 |
TRP ankyrin 1 |
TRPM2 |
TRP melastatin 2 |
TRPMLs |
TRP mucolipins |
UPECs |
uropathogenic Escherichia coli |
UTIs |
urinary tract infections |
VacA |
vacuolating cytotoxin A |
V-ATPase |
vacuolar H+-ATPase |
VGCC |
voltage-gated Ca2+ channel |